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Prevention of Iron Deficiency Anemia in Infants and Toddlers 
ABSTRACT: Anemia, defined as a low blood hemoglobin concentration, is a major global public 
health problem. Identification of anemia is crucial to public health interventions. It is estimated 
globally that 273 million children under 5 years of age were anemic in 2011, and about ~50% of 
those cases were attributable to iron deficiency (1). Iron deficiency anemia (IDA) in infants 
adversely impacts short-term hematological indices and long-term neuro-cognitive functions of 
learning and memory that result in both fatigue and low economic productivity. IDA contributes to 
death and disability and is an important risk factor for maternal and perinatal mortality, including 
the risks for stillbirths, prematurity and low-birth weight (2). Reduction in early infantile anemia 
and newborn mortality rates is possible with easily implemented, low- to no-cost intervention such 
as delayed cord clamping (DCC). DCC until one to three minutes after birth facilitates placental 
transfusion and iron-rich blood flow to the newborn. DCC, an effective anemia prevention strategy 
requires cooperation among health providers involved in childbirth, and a participatory culture 
change in public health. Public intervention strategies must consider multiple factors associated 
with anemia listed in this review before designing intervention studies that aim to reduce anemia 
prevalence in infants and toddlers. 
 
 
 
 
 
 
 
INTRODUCTION  
Anemia is a condition in which hemoglobin (Hb) concentration is lower than the normal expected 
ranges for age and sex (3, 4). The definition of anemia is not straightforward, and one must 
consider age-specific variation in Hb cut offs, clinical, environmental, population distribution of Hb 
values and ethnic variation besides laboratory and diagnostic considerations for Hb measurement 
(5).  Physiologically, anemia is defined as a condition in which the number of circulating red blood 
cells is insufficient to meet the oxygen requirement of tissues and the body’s physiologic needs. 
Hb thresholds differ for different population groups. Regardless of the type of definition, Hb levels 
below an established cut-off value impairs the capacity of RBCs to transport oxygen. The resultant 
tissue hypoxia result in fatigue and impairment of work capacity with negative consequences to 
both physical and cognitive development (6, 7). Anemia is an indicator of both poor nutrition and 
poor health. One in four people are affected by anemia, and the most vulnerable populations are 
pregnant women and preschool-age children (0-4.99 yrs) (8).  
               Anemia can result from multiple causes including nutritional deficiency, infection and 
inflammation from disease, acute or chronic blood loss and genetic hemoglobin disorders. 
However, iron deficiency is the most common cause of anemia world-wide (9). Iron deficiency 
anemia (IDA) is a widespread public health problem, particularly in low- and middle- income 
countries. The World Health Organization (WHO) estimates globally that ~273 million young 
children under 5 years are anemic, among which ~50% are estimated to suffer from iron 
deficiency (4, 8). There is a high demand for dietary iron during infancy and pre-school years to 
support physical growth, rapid brain development, and early learning capacity (10, 11). Prompt 
identification and treatment of anemia leads to overall improvement of population health 
outcomes, improved physical exercise performance, and well-being that results in enhanced 
economic productivity. The focus of this review will be on the determinants and solutions to IDA 
including development of an anemia-control strategy that specifically targets infants under 1 year 
of age and toddlers.  
 
GLOBAL PREVALENCE OF ANEMIA 
Figures 1 a thru c depict the global estimates of the prevalence of anemia as a public health 
problem in infants and children aged 6-59 months, pregnant women aged 15-49 years, and in 
non-pregnant women aged 15-49 years, 2011 (4). In 2011, population-representative data 
sources from 107 countries worldwide revealed that 29% (496 million) of non-pregnant women 
and 38% (32.4 million) of pregnant women aged 15-49 years were reported to be anemic (1). 
Anemia prevalence continues to be highest in South Asia and Central and West Africa (1). 
Prevalence of IDA among infants and preschoolers living in rural India was 52.2% and 42.1% 
(12). In 2012, the World Health Assembly specified six global nutrition targets for 2025, with a 
commitment for a 50% reduction of anemia in women of reproductive age by 2025 compared to 
2011 levels (13). Table 1 summarizes the top 10 countries across the globe with the highest 
incidence/burden of iron deficiency.  
 
EFFECT OF IDA ON MATERNAL MORTALITY 
Low Hb during pregnancy has been associated with an increased risk of maternal mortality (2),  
perinatal mortality and low birth weight / small-for-gestational-age outcomes (14-16). Table 2 
summarizes the 10 countries with the highest incidence/burden of maternal deaths across the 
globe. Hypertensive disorders and hemorrhage further contribute to maternal deaths during 
pregnancy and childbirth (17). Worldwide, the annual number of maternal deaths has been on a 
decline. From nearly 600,000 women between the ages of 15 and 49 dying each year as a result 
of pregnancy and childbirth related complications with overwhelming majority in the developing 
nations in 1990 (18), the annual number of maternal deaths has decreased since then by 43 
percent, down to 303,000 in 2015 (19, 20). Despite declining maternal deaths, in developing 
nations, pre-existing conditions such as IDA are an important contributor to overall global maternal 
mortality, especially when it occurs in pregnancy. Maternal and neonatal mortality were 
responsible for 3.0 million deaths in 2013 to further contribute to overall global mortality (21). It 
has been estimated that 90,000 deaths in both sexes and all age groups are due to IDA alone 
(21). 
 
EFFECT OF IDA ON INFANT MORTALITY AND UNDER 5 YEAR MORTALITY 
Worldwide, mortality for children under age five years has been on a decline by almost 50% from 
12.4 million in 1990 to 5.9 million in 2015 (22). Despite the global decline, the number of deaths 
remain highest in the neonatal period (the first 28 days of life). Causes of neonatal deaths include 
preterm birth complications (0.965 million, 15.4%), and intra-partum related complications (0.662 
million, 10.5%) (23). Infectious diseases such as pneumonia and diarrhea (3.257 million, 51.8%) 
are the leading causes of mortality of children under five years of age. Newborn mortality currently 
accounts for 30 to 50% of all deaths among children younger than 5 years of age in Sub-Saharan 
Africa and South Asia (24-27). Table 3 summarizes the 10 countries with the highest 
incidence/burden of infant mortality and under 5 mortality. According to the WHO, The Democratic 
Republic of Congo, Ethiopia, India, Nigeria, and Pakistan collectively contributed to nearly 50% 
of the total number of global under age five years death (48.3 percent, 2.871 million) and neonatal 
deaths (50.8 percent, 1.3662 million) in 2015 (22). Anemia contributes to child mortality through 
malnutrition, and increased susceptibility to infection, especially in African and Southeast Asian 
countries (2).  
 
CONSEQUENCES OF IDA  
EFFECTS OF IDA ON THE DEVELOPING BRAIN 
Both iron deficiency and anemia are associated with perinatal mortality, delayed child mental and 
physical development, and reduced visual and auditory function (28-30). Iron is critical for normal 
myelin synthesis (7). Myelin producing oligodendrocytes require iron for both maturation and 
function (31, 32).  Early iron deficiency adversely affects the developing brain through alteration 
in myelination and major dopamine pathways (33, 34). Anemia affects intelligence, perhaps with 
irreversible and lifelong consequences on cognition, translating to the equivalent of a 5-10 point 
deficit in intelligence quotient (35). Moreover, IDA at an early age may be associated with 
permanent cognitive impairment, which may be irreversible even after repletion of iron stores (30, 
36). Lozoff and others have demonstrated that iron deficiency, aside from causing hematological 
abnormalities, has long-lasting neurocognitive impairment (37, 38) with adverse effects on infant 
psychomotor development (39, 40). Iron has a critical role in both learning and memory including 
the speed of optimal brain processing (41). The developing hippocampus is especially vulnerable 
to early iron deficiency (41). One possible mechanism of the negative impact of iron deficiency on 
learning and memory is through abnormalities in hippocampal neuronal differentiation, reduction 
in metabolic activity and altered gene expression in the rat hippocampus relative to other brain 
regions as demonstrated in a rodent model (41-43). Children and young adults with iron deficiency 
as infants showed poorer inhibitory control and executive functioning when assessed by 
neurocognitive tasks (33). Studies by Lozoff et al and Walter et al have shown that Iron-deficient 
infants at age 5 and 10 years consistently showed impaired cognitive development with a 5-point 
drop in intellectual quotient, lower school achievement and poorer fine-hand movements (7, 44). 
 
EFFECTS OF IDA ON WORK PRODUCTIVITY 
    Iron deficiency has been associated with reduced work capacity (6).  Iron deficiency affects 
cognitive ability and skill acquisition, which in turn adversely impacts overall work productivity 
(45). The median annual economic loss because of IDA in 10 developing countries was estimated 
at $16.78 per capita (in 1994 US dollars), or 4% of gross domestic product (45). Fixing the problem 
of IDA  in developing nations could result in a 20% increase in economic productivity over the life 
of an infant (36). As the iron status in an individual improves, the amount of physiological energy 
required to complete work-related task decreases. This results in increased physical fitness, less 
fatigue, more energy efficiency and greater engagement in work-related activities.  
 
DIFFERENCES BETWEEN IRON DEFICIENCY AND IDA 
Iron deficiency is a state of reduction or depletion in iron stores. Untreated iron deficiency 
progresses to a state of IDA where the Hb concentrations are reduced and red blood cells become 
hypochromic and microcytic. Anemia is most frequently assessed through measurement of blood 
Hb concentration on either capillary or venous blood. As Hb is known to have natural variation by 
age, sex, and physiological status (ex: pregnancy), Hb concentration below established sex-, age- 
and pregnancy-specific cut-off values is indicative of anemia (46). Measurement of Hb 
concentration is possible using relatively inexpensive equipment and does not require highly 
skilled individuals for testing. In addition, non-invasive methods of measuring Hb in newborn 
infants with using white light spectroscopy have been developed (Rabe 2010). For children aged 
6-59 months, Hb concentration below 11g/L indicates anemia. In order to determine whether 
anemia is secondary to iron deficiency, one must monitor additional measures of iron status such 
as reticulocyte Hb, serum ferritin, serum transferrin receptor, total iron binding capacity, transferrin 
saturation, zinc protoporphyrin concentration, and erythrocyte protoporphyrin concentration. 
Reticulocyte Hb is a clinically useful marker for determining iron deficiency and hematological 
responses during iron administration (47) and is an emerging biomarker as an alternative to 
biochemical iron studies in the diagnosis of IDA (48). There are newer regulators of iron 
homeostasis such as the hepatic peptide hormone hepcidin that are stimulated by inflammation 
(49). Serum hepcidin quantification assays are increasingly being used to both identify iron 
deficiency (50) and determine intestinal absorption response to iron administration (51). It is 
important to remember that IDA is the final stage of ID and is not an early marker of iron 
deprivation (52). Figure 2 [adapted from the WHO (53)] illustrates the change in the different 
biochemical indices of iron status from normal to functional iron deficiency. It is also important to 
remember that despite ferritin being recommended as the primary measure of iron status, 
interpretation of ferritin values are challenging in settings with infection and inflammation (54).  
 
RISK FACTORS AND CAUSES OF IDA 
 Understanding the etiology and risk factors for anemia is very important in order to execute 
effective and strategic interventions that control anemia prevalence. Risk factors for IDA in infants 
includes those in the perinatal, and infancy period. Perinatal risk factors include maternal iron 
deficiency, prematurity, and perinatal hemorrhagic events such as twin-twin transfusion or fetal-
maternal hemorrhage. Specific neonatal populations at greatest risk factors for IDA include small 
for gestational age infants, extremely low birth weight infants, and infants of diabetic mothers. 
Infantile risk factors include a) primarily dietary factors such as prolonged exclusive breast-feeding 
in the absence of timely introduction of iron rich complementary feeds (55), use of low-iron infant 
formula, feeding of unmodified (non-formula) cow’s milk, goat’s milk or soy milk, insufficient iron-
rich complementary foods, and excessive intake of cow’s milk (52) and b) non-dietary risk factors 
include recurrent respiratory tract infections, chronic infections such as malaria and HIV, 
gastrointestinal (GI) malabsorptive diseases including coeliac disease, chronic intestinal 
infections / infestations and disorders with GI blood loss such as milk protein-induced 
enterocolitis, hook worm infestation, and inflammatory bowel disease. A largely-cereal based diet 
rich in phytates, polyphenols and other ligands that are known to inhibit intestinal iron absorption 
predominate in developing countries (56-58). The prevalence of anemia and IDA among infants 
aged 9-12 months from a random sample in Nablus Governorate, north of Jerusalem, was 34.6% 
and 32.6% (Salah RW, J Res Health Sci 2018). Predictors of IDA in this population were infant’s 
age, maternal anemia during the third trimester, birth spacing less than three years, exclusive 
breast feeding during the first six months, early and late introduction of complementary feeding 
and non-compliance to iron supplement in the correct frequency and duration during pregnancy. 
 
PREVENTIVE INTERVENTIONS TO CONTROL IDA 
Anemia preventive strategies are effective when approached in an integrated, coordinated, and 
targeted manner. For any intervention that is aimed to successfully reduce the prevalence of IDA 
in infants, intervention strategies must focus on one or more of the following: Identifying the 
different dietary and non-dietary risk factors for IDA, especially in pregnant women and their 
infants; establishing a cost-effective, readily accessible, easily affordable, and sustainable 
intervention in the less-developed regions of the world that can be widely delivered and distributed 
to the target population and readily made available through locally operated health care facilities; 
and simultaneously tackling the problem of inflammation associated with chronic infection and 
infestation such as malaria, vitamin A deficiency and hookworm infestation.  
 
INTERVENTIONS IN EARLY INFANCY – DELAYED CORD CLAMPING / UMBILICAL CORD 
MILKING 
Non-dietary intervention such as delayed clamping of the umbilical cord (DCC) targets early 
infantile anemia (McDonald 2013, Rabe 2012). DCC has a direct impact on preventing early 
infantile anemia by facilitating placental transfusion (59). Waiting to cut the umbilical cord until 
sufficient time (1 to 3 mins) has elapsed to permit blood flow from placenta to newborn while the 
baby is transitioning to extra uterine life has enormous benefits to the neonate. Currently, the 
umbilical cord is generally clamped within 15 seconds of birth (60). The newborn is then quickly 
transferred to the pediatric provider to avoid delayed resuscitation. Clamping the umbilical cord 
while significant circulation is still occurring through the umbilical vessels drops the cardiac output 
by about 40% (61). This deprives the newborn of the benefit of added circulating blood volume 
(up to 100ml) from continuing placental transfusion. This relatively simple, inexpensive, and 
straightforward intervention of DCC when put into effective practice can save lives. Placental 
transfusion can also be accomplished by umbilical cord milking (UCM) or cord milking through a 
cut umbilical cord (62, 63). Milking refers to the manual expression of blood from the umbilical 
cord by actively squeezing or milking blood down a short segment of umbilical cord (20-30cms) 
that is either cut (cut cord) or attached (intact cord) to the placenta towards the baby 3-4 times at 
a rate of 10 cm/sec before clamping the cord (64). UCM can serve as an alternative to DCC in 
situations of hypoxic term infant deliveries by simultaneously providing added blood volume from 
the accelerated process of placental transfusion and not jeopardize timely resuscitative efforts 
(62-64). 
 
IMPACT OF DCC ON IRON DEFICIENCY 
A significant amount of iron-rich red blood cells remains in the placental circulation when the cord 
is clamped early, depriving the newborn of iron-carrying red blood cells. The greatest benefit of 
DCC is seen in children born at term to iron-deficient mothers and babies with birth weights of 
less than 3000g (65). In term infants, a one-minute delay in cord clamping after birth led to 
additional volumes upto 80ml of blood from the placenta to the infant’s circulation, which 
increased to 100ml by 3 minutes after birth (66, 67). Delaying cord clamping by around 3 mins 
provides an additional 40ml blood volume per Kg of bodyweight through placental transfusion with 
the potential to contribute up to 75mg of iron in a baby weighing 3Kg, thereby preventing iron 
deficiency in infant’s first six months of life (59, 68-72). A large RCT in Mexico of 476 infants 
randomized to 2 minutes of DCC vs. early cord clamping demonstrated  that a 2 minute DCC 
increased 6-month iron stores by about 27-47 mg at 6 months of age (65).  
Higher Hb, hematocrit and ferritin levels were observed after UCM in term and late-preterm infants 
when compared to immediate cord clamping group at 6 weeks of age (64, 73, 74). While UCM 
may serve as an alternative to DCC by providing equivalent benefits in term infants and not 
delaying timely resuscitation, in a post-hoc analysis of a randomized clinical trial of UCM vs DCC 
for 45-60 seconds among preterm infants born <32 weeks gestation, there was a statistically 
significant higher rate of severe intraventricular hemorrhage in the UCM group that led to early 
study termination (75). On the contrary, three other studies with similar study design in preterm 
infants did not find such a difference in rates of intraventricular hemorrhage in the UCM group 
(76-78). Further clinical trials are needed to investigate the potential benefits of DCC vs UCM in 
preterm infants. Until then, extreme caution must be exercised while practicing UCM in the 
extremely preterm population. 
 
IMPACT OF DCC ON IDA 
DCC serves as a low-cost non-dietary intervention to reduce the risk for IDA (67, 68, 79). At 4 
months, infants born at term receiving DCC had greater ferritin levels and increasing myelin in 
brain areas important for early life functional development (80). A positive association between 
maternal iron stores reflected in plasma ferritin concentration with infant plasma ferritin in the first 
six months has been observed (81). In a RCT of 276 mother-infant pairs, DCC at 3 minutes 
significantly increased serum ferritin levels in term infants at 6 months of age compared to early 
clamping group with a 3 times higher incidence of IDA among infants receiving early cord 
clamping (82). Moreover, DCC, when compared to early clamping, improved fine motor function 
at four years, indicating that optimizing the time to cord clamping has a positive impact on 
neurodevelopment (28). Full-term infants benefit from increased hemoglobin, increased iron 
stores, and better motor outcomes at 4 years of age (4, 14-16). The WHO recommends delayed 
clamping of the umbilical cord to reduce infant anemia (79). DCC serves as a means to deliver 
iron, potentially reducing or eliminating the cost of iron supplements (66). As an alternative to 
DCC, keeping the umbilical cord long and milking may be an effective method for improving Hb 
and iron stores at 6 months of age in term-infants. Higher ferritin levels were observed at 6 months 
of age in the UCM group, regardless of maternal anemia status, compared to the immediate cord 
clamping group (83). Thereafter, both DCC and UCM interventions are particularly relevant for 
infants living in low-resource settings or in settings with less access to iron-rich foods and thus, 
greater risk of anemia. 
Preterm infants have the added benefit of a 27% increase in survival rate if they receive DCC at 
birth (Rabe 2019). In these infants, DCC enables a better transition to extrauterine life by 
increasing blood pressure and reducing the need for volume therapy, blood transfusions and 
inotropes. Due to additional iatrogenic blood losses, preterm infants benefit thereafter from a 
combination strategy of DCC, limited phlebotomy blood sampling and early introduction to 
adequate protein and iron supply to boost endogenous erythropoiesis. Iron supplementation 
starting from the early neonatal period has been shown to be beneficial to both preterm and term 
infants. A combined approach of a 30 sec DCC, early protein and iron supplementation (6 mg/kg 
from Days 7 to 10 of life) and change to a restrictive transfusion threshold resulted in a reduced 
number of RBC transfusions by half in preterm infants <32 weeks gestational age and < 1500 g 
birth weight population (84). In a randomized interventional trial, early supplementation of iron at 
a dose of 2 mg/kg from the second day after birth improved both iron status and motor 
development at 6 months in term infants at risk for early iron deficiency compared with the no 
iron-supplementation group (85) 
 
IMPACT OF DCC ON MATERNAL HEALTH 
Post-partum hemorrhage (PPH), is defined as a blood loss of 500 ml or more within 24 hours after 
birth. Reduction in PPH risk directly impacts maternal health (86). According to the WHO, PPH is 
associated with nearly one-quarter of all maternal deaths globally, and is the leading cause of 
maternal mortality in most low-income countries (87). As anemia contributes to 20% of all 
maternal deaths, PPH is a burden for anemic mothers in the perinatal period. Any intervention 
that reduces the risk of PPH could impact maternal morbidity and mortality (Kavle, Stoltzfus et al. 
2008). Most PPH is avoidable through timely and appropriate management of the third stage of 
labor, which begins after the birth of the baby and ends with delivery of the placenta and fetal 
membranes. There appears to be no risk to the mother of a delay of 1-3 minutes to clamping the 
umbilical cord, and this practice could potentially prevent the mother from becoming anemic 
during the third stage of labor by facilitating optimal delivery of the placenta and reducing the risk 
of PPH (88, 89). Studies have shown that the incidence of PPH is not increased with DCC for 1-
3 minutes (67, 90, 91). The 2012 WHO guidelines for the management of PPH strongly endorse 
DCC for all infants that do not require immediate resuscitation after both vaginal and caesarean 
births (87).  
                              Despite endorsements by numerous governing bodies (Table 4), including the 
WHO, the American Academy of Pediatrics, the American College of Obstetrics and Gynecology, 
the European Association of Perinatal Medicine, the Society of Obstetricians and Gynecologists 
of Canada, the Royal College of Obstetricians and Gynaecologists and the International Liaison 
Committee on Resuscitation, the practice of DCC has been slow to be adopted (92). In a review 
by Anton et al,  reported barriers and strategic methods to improve placental transfusion protocol 
were closely examined (92). Preferred methods of successful implementation of DCC to establish 
placental transfusion include protocol development, and targeted education of the stakeholders 
involved in obstetric and pediatric practice through simulation exercises, as well as feedback and 
auditing of placental transfusion practice through quality improvement projects (93-96). 
 
INTERVENTIONS IN LATE INFANCY AND TODDLERS – IRON FORTIFICATION 
Despite the observed protection against early infantile iron deficiency from placental transfusion 
of maternal iron stores, prevalence of anemia continues to remain high among infants aged 7-12 
months. In maternal-infant pairs from a peri-urban municipality in Nepal (81), prevalence of 
anemia among infants aged 7-12 months was 72% (Hb <11.3g/dL). According to WHO, while 
infants should be exclusively breastfed for the first six months of life, beyond six months, infants 
should receive nutritionally adequate and safe complementary foods, to achieve optimal growth 
and development (53).  
                     There is a major global nutrition effort to decrease iron deficiency anemia through 
the provision of iron fortified food. Iron deficiency can be treated with dietary oral iron 
supplementation, intravenous iron therapy and/or red cell transfusion, depending on the patient’s 
Hb status and underlying co-morbid illness. Dietary intervention with iron supplementation and 
fortification of infant food with iron addresses late infantile anemia. Iron is considered an essential 
dietary component and is necessary for development and health. The recommended dietary 
allowance for total iron intake (mg/d) during early infancy (0-6 months) is 0.27 mg/d and late 
infancy (7-12 mon) is 11 mg/d (97, 98). Dietary iron is a widely administered supplement for 
pregnant women and is a key ingredient in infant formulas. Food items that are rich in iron content 
include liver, legumes, beans, nuts, green leafy vegetables and fortified cereals, but have very 
variable bio-absorption (57). Daily oral iron supplementation is a commonly recommended 
intervention both for treatment and prevention of anemia related to iron deficiency. In an effort to 
prevent infantile anemia, the WHO recommends use of fortified foods or home fortificants such 
as micronutrient powders or lipid-based nutrient supplements for feeding non-breastfed children 
6-24 months of age (99). Iron supplementation has been shown to benefit infants with the poorest 
iron status (53). Moreover, healthy full-term un-supplemented infants at 12 months of age showed 
less positive response to both physical and social environment compared to the iron 
supplemented group in the first year of life after initiating iron supplementation from 6 months of 
age (100). This study highlights the potential for reversing a preventable intellectual deficit from 
iron deficiency if oral iron supplementation is started early in infancy. 
 
MEASURES OF SUCCESSFUL ORAL IRON SUPPLEMENTATION AND IMPROVEMENT OF 
MATERNAL-INFANT IRON STORES 
The WHO recommends daily iron supplementation as a public health intervention in infants and 
young children aged 6-23 months, living in settings where the prevalence of anemia is 40% or 
higher in order to prevent iron deficiency and anemia (53). Suggested schemes include daily iron 
supplement of 10-12.5mg elemental iron either as drops or syrup for three consecutive months 
per year. The WHO also recommends a supervised provision of iron supplementation in malaria-
endemic areas in conjunction with local public measures to prevent, diagnose and treat malaria 
(101). In Venezuela, the prevalence of anemia in children aged 7, 11 and 15 years decreased by 
50% within 12 months of introduction of iron fortification of flours that included precooked maize 
and white wheat (102). 
                     Improvement of maternal iron stores in women of reproductive age-group is vital in 
order to improve pregnancy outcomes for mothers and infants (53).  Iron supplementation during 
pregnancy increases maternal and fetal iron stores with >66% of the infant’s total body iron being 
acquired during the final trimester of pregnancy (103). The WHO recommends daily oral iron and 
folic acid supplementation with 30-60mg of elemental iron and 400 µg (0.4mg) folic acid for 
pregnant women and adolescent girls to prevent maternal anemia, puerperal sepsis, low birth 
weight and preterm birth (104). A small iron cooking tool such as the Lucky Iron Fish that infuses 
meals with iron can serve as an alternative to help prevent iron deficiency and anemia, especially 
in conditions when iron-fortified diet is neither affordable nor possible, and supplements are 
expensive, not consistently available, and often culturally unacceptable (105). Lucky Iron Fish are 
fish-shaped cast iron ingots. The ingots are placed in a pot of boiling water to leach elemental 
iron into the water and food. The ingots provide dietary supplementation of iron to individuals 
affected by iron-deficiency anemia when used as directed during the cooking process. Lucky Iron 
Fish can restore circulating and stored levels of iron and reduces the prevalence of anemia by 
∼43% (105).  
          Improvements in the prevalence of anemia among women of reproductive age through 
successful implementation strategies are being observed globally. In Viet Nam, the prevalence of 
anemia fell from 38% at baseline to 19% after 12 months of weekly iron-folic supplementation in 
conjunction with de-worming among women of reproductive age 15-45 yrs. Furthermore, 
continued use of this program intervention led to elimination of IDA in Venezuela as the 
prevalence of IDA fell further from 18% to 4% at 54 months post-implementation (106). In India, 
evaluation of a pilot program of weekly iron-folic supplementation to over 1.2 million adolescent 
girls led to reduction in the prevalence of anemia from 74.2% to 53.5% within one year, with 
estimated compliance greater than 90% (107). A universal iron supplementation strategy was 
effective in reducing the prevalence of anemia among low-income postpartum women across 
eleven health clinics in Mississippi. The prevalence of anemia among low-income postpartum 
women (Hb < 12.0g/dl) dropped from 52% to 33% at 6 months after the intervention (49). In 
Thailand, between 1986 and 1996/97, anemia prevalence reduced by 50% in pregnant women 
through provision of free iron and folic supplementation (108). The above studies demonstrate 
that population-based interventions can efficiently and effectively reduce anemia but requires 
cooperation of the local health authorities besides nutritional education of the community.  
                Despite universal iron supplementation strategy being effective in reducing the 
prevalence of anemia among low-income postpartum women, challenges remain in the pre-
school population. The global burden of anemia remains high especially in low-income settings 
of Africa and parts of Asia even after distribution of iron. Anemia prevalence continues to be high 
among infants and preschoolers in India (12). In India, the current anemia prevalence among pre-
school aged children (0-4.99 yrs) and pregnant mothers (15-49 yrs) is 59% and 54%. Various 
cost-effective interventions and policies including the National Nutrition Policy, Integrated Child 
Development Services, Mid-day Meal Programme and other initiatives under National Rural 
Health Mission are currently being implemented that facilitates prevention and control of anemia 
in infants and women of reproductive age.   
 
RISKS OF ROUTINE IRON SUPPLEMENTATION  
There are concerns of potential adverse effects to children from iron supplementation regimens 
such as increased risk for malarial parasitaemia in malaria-endemic regions (35). It has been 
shown that iron deficiency offers protection against malaria infection, although the precise 
mechanism of this protective benefit remains unknown (109, 110). In a meta-analysis of sixty-
eight trials, Ojukwu et al showed that iron does not increase the risk of clinical malaria or death, 
when regular malaria surveillance and treatment services are provided (111). Regardless, 
guidelines for iron supplementation that will provide greatest benefit with least harm in areas with 
high malaria prevalence requires further clarification. There is also an added urgency to clarify 
the safety of iron supplementation and fortification where inherited Hb disorders are highly 
prevalent. Currently WHO does not offer guidelines on iron supplementation in settings of 
inherited red cell disorders and other hemoglobinopathies. The safety of long-term iron 
supplementation in inherited Hb disorders, a population at risk for iron overload, has not been 
established. Other risks of oral iron supplementation include gastrointestinal side effects including 
vomiting in upto 50% of adult patients leading to reduced tolerance and adherence to iron 
supplementation (112, 113). Based on a systematic review, extended release ferrous sulfate with 
mucoproteose appeared to be the best tolerated of the several oral iron supplements evaluated 
by the study group (113). Newer innovative oral iron formulation such as sucrosomial iron with its 
protective phospholipid bilayer that offers higher iron bioavailability and improved gastrointestinal 
tolerance are emerging (114).  
 
CONCLUSION 
In summary, anemia reduction interventions in neonates, infants, and toddlers must start with:  
1. Universal implementation of delayed umbilical cord clamping; 2. In populations where anemia 
is a public health problem, provide point-of-use fortification of complementary foods with iron-
containing micronutrient powders to infants and preschool children; 3. Control of inflammation 
through prevention and treatment of HIV, malaria and helminthic infections in children aged under 
3 years; 4. Counselling of pregnant women on optimal dietary practices and 5. Raising awareness 
of anemia prevention programs through a) community participation, b) strengthening of various 
existing preventive programs through integration and coordination, c) Sustained training and 
surveillance of healthcare workers and d) increase compliance among beneficiaries through 
public-private partnerships.  
                  IDA continues to be a major contributor to overall anemia prevalence worldwide. 
Limited health services undeniably are a major factor for high maternal and perinatal mortality in 
resource-limited settings. Public intervention strategies must consider the various factors 
associated with anemia before designing intervention studies to reduce anemia prevalence. 
Anemia preventive strategies are effective when approached in an integrated, coordinated, and 
targeted manner. Collaborative partnerships from governmental and non-governmental 
organizations and local communities are vital to achieving successful reduction of the prevalence 
of anemia in infants and toddlers.  
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Figure Legends 
Figure 1a: Global prevalence of anemia in infants and children aged 6-59 months, 2011 
Figure 1b: Global prevalence of anemia, pregnant women aged 15-49 years, 2011 
Figure 1c: Global prevalence of anemia, non-pregnant women aged 15-49 years, 2011 
Figure 2: Indices for assessing iron status at various stages of iron deficiency anemia 
  
 
 
